420 related articles for article (PubMed ID: 27650822)
1. β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.
Puymirat E; Riant E; Aissaoui N; Soria A; Ducrocq G; Coste P; Cottin Y; Aupetit JF; Bonnefoy E; Blanchard D; Cattan S; Steg G; Schiele F; Ferrières J; Juillière Y; Simon T; Danchin N
BMJ; 2016 Sep; 354():i4801. PubMed ID: 27650822
[TBL] [Abstract][Full Text] [Related]
2. Discharge heart rate and mortality after acute myocardial infarction.
Seronde MF; Geha R; Puymirat E; Chaib A; Simon T; Berard L; Drouet E; Bataille V; Danchin N; Schiele F
Am J Med; 2014 Oct; 127(10):954-62. PubMed ID: 25004457
[TBL] [Abstract][Full Text] [Related]
3. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.
Krumholz HM; Radford MJ; Wang Y; Chen J; Heiat A; Marciniak TA
JAMA; 1998 Aug; 280(7):623-9. PubMed ID: 9718054
[TBL] [Abstract][Full Text] [Related]
4. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
6. Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.
Neumann A; Maura G; Weill A; Alla F; Danchin N
Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004356. PubMed ID: 29653999
[TBL] [Abstract][Full Text] [Related]
7. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
[TBL] [Abstract][Full Text] [Related]
8. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
[TBL] [Abstract][Full Text] [Related]
9. Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery.
Chan AY; McAlister FA; Norris CM; Johnstone D; Bakal JA; Ross DB;
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):182-7, 187.e1. PubMed ID: 20427056
[TBL] [Abstract][Full Text] [Related]
10. Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.
Quint JK; Herrett E; Bhaskaran K; Timmis A; Hemingway H; Wedzicha JA; Smeeth L
BMJ; 2013 Nov; 347():f6650. PubMed ID: 24270505
[TBL] [Abstract][Full Text] [Related]
11. β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.
Dondo TB; Hall M; West RM; Jernberg T; Lindahl B; Bueno H; Danchin N; Deanfield JE; Hemingway H; Fox KAA; Timmis AD; Gale CP
J Am Coll Cardiol; 2017 Jun; 69(22):2710-2720. PubMed ID: 28571635
[TBL] [Abstract][Full Text] [Related]
12. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
[TBL] [Abstract][Full Text] [Related]
13. Benefit of Vasodilating β-Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study.
Chung J; Han JK; Kim YJ; Kim CJ; Ahn Y; Chan Cho M; Chae SC; Chae IH; Chae JK; Seong IW; Yang HM; Park KW; Kang HJ; Koo BK; Jeong MH; Kim HS;
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066446
[TBL] [Abstract][Full Text] [Related]
14. Association between functional status and use and effectiveness of beta-blocker prophylaxis in elderly survivors of acute myocardial infarction.
Vitagliano G; Curtis JP; Concato J; Feinstein AR; Radford MJ; Krumholz HM
J Am Geriatr Soc; 2004 Apr; 52(4):495-501. PubMed ID: 15066062
[TBL] [Abstract][Full Text] [Related]
15. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U
Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805
[TBL] [Abstract][Full Text] [Related]
16. Heart failure in acute myocardial infarction: a comparison between patients with or without heart failure criteria from the FAST-MI registry.
Juillière Y; Cambou JP; Bataille V; Mulak G; Galinier M; Gibelin P; Benamer H; Bouvaist H; Méneveau N; Tabone X; Simon T; Danchin N;
Rev Esp Cardiol (Engl Ed); 2012 Apr; 65(4):326-33. PubMed ID: 22357361
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention.
Ozasa N; Kimura T; Morimoto T; Hou H; Tamura T; Shizuta S; Nakagawa Y; Furukawa Y; Hayashi Y; Nakao K; Matsuzaki M; Nobuyoshi M; Mitsudo K;
Am J Cardiol; 2010 Nov; 106(9):1225-33. PubMed ID: 21029817
[TBL] [Abstract][Full Text] [Related]
18. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
Soumerai SB; McLaughlin TJ; Spiegelman D; Hertzmark E; Thibault G; Goldman L
JAMA; 1997 Jan; 277(2):115-21. PubMed ID: 8990335
[TBL] [Abstract][Full Text] [Related]
19. Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction.
Rochon PA; Tu JV; Anderson GM; Gurwitz JH; Clark JP; Lau P; Szalai JP; Sykora K; Naylor CD
Lancet; 2000 Aug; 356(9230):639-44. PubMed ID: 10968437
[TBL] [Abstract][Full Text] [Related]
20. Patterns of statin prescription in acute myocardial infarction: the French registry of Acute ST-elevation or non-ST-elevation Myocardial Infarction (FAST-MI).
Ferrières J; Bataille V; Leclercq F; Geslin P; Ruidavets JB; Grollier G; Bernard P; Cambou JP; Simon T; Danchin N
Atherosclerosis; 2009 Jun; 204(2):491-6. PubMed ID: 19004441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
